Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Farris

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Molecular Therapy. Methods & Clinical Development|September 23, 2021
Defining the optimal dose and therapeutic window in SMA with respiratory distress type I model mice, FVB/NJ-<i>Ighmpb2</i> <sup></sup>Monir Shababi, Caley E Smith, Sara M Ricardez Hernandez, et al.
Plos One|October 16, 2020
COVID-19 observations and accompanying dataset of non-pharmaceutical interventions across U.S. universities, March 2020Kevin E Cevasco, Hayley M North, Sheryne A Zeitoun, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Molecular Therapy. Methods & Clinical Development|September 23, 2021
Defining the optimal dose and therapeutic window in SMA with respiratory distress type I model mice, FVB/NJ-<i>Ighmpb2</i> <sup></sup>Monir Shababi, Caley E Smith, Sara M Ricardez Hernandez, et al.
Plos One|October 16, 2020
COVID-19 observations and accompanying dataset of non-pharmaceutical interventions across U.S. universities, March 2020Kevin E Cevasco, Hayley M North, Sheryne A Zeitoun, et al.
Pageof 2